Gene and cellular immunotherapy for cancer / Armin Ghobadi, John F. DiPersio, editors.
Clinical and preclinical exploration of gene and cellular immunotherapy have seen rapid growth and interest with the development and approval of five Chimeric Antigen Receptor T-cell (CAR-T) products for lymphoma and myeloma and one Bispecific T-Cell Engager (BiTE) for acute lymphoblastic leukemia (...
Full description
Saved in: